To include your compound in the COVID-19 Resource Center, submit it here.

IntraDose cisplatin/epinephrine injectable gel regulatory update

MATX received a non-approvable letter from the FDA

Read the full 88 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE